Literature DB >> 29385434

Importance of comorbidities in the treatment of primary care patients with heart failure-Baseline results of the observational RECODE-HF Study.

Marion Eisele1, Winfried Adam1, Anja Rakebrandt1, Sigrid Boczor1, Eva Blozik1, Jens-Martin Träder2, Stefan Störk3, Christoph Herrmann-Lingen4, Martin Scherer1.   

Abstract

Background: Both non-cardiac and cardiac comorbidities are related to the prognosis of chronic heart failure (HF), but so far little is known about the impact of comorbidities on treatment difficulties in routine care.
Objectives: To investigate which comorbidities are associated with treatment difficulties in primary care. We hypothesized that somatic comorbidities as well as psychosocial distress are associated with treatment difficulties.
Methods: In this baseline analysis of data of the observational RECODE-HF study, HF patients were recruited via primary care practices in two German sites. They received a questionnaire by mail to measure psychosocial distress. Each patient's GP was interviewed by phone regarding the patient's comorbidities and treatment difficulties. Logistic regression analyses controlled for GP cluster effects were calculated to investigate the association between comorbidities/psychosocial distress and treatment difficulties.
Results: The 3282 patients of 285 GPs included in the analysis were aged 74.2 (±10.1) years and had a mean number of 4.6 (±2.4) comorbidities. GPs reported treatment difficulties in 32.5% of the patients. Allergies/drug intolerance [odds ratio (ORs)=2.0], asthma/chronic obstructive pulmonary disease (ORs=1.4), renal insufficiency (ORs=1.3), atherosclerosis/peripheral arterial occlusive disease (ORs=1.3) and cardiac arrhythmias (ORs=1.2) as well as patient-reported psychosocial distress (ORs=1.2), HF severity (ORs=3.7-1.6) and age (ORs=0.98) were associated with treatment difficulties.
Conclusion: Five somatic comorbidity groups as well as patient-reported psychosocial distress were significantly associated with a higher risk of GP-reported treatment difficulties. Further efforts to address comorbidities in clinical guidelines could be built on these results.

Entities:  

Mesh:

Year:  2018        PMID: 29385434     DOI: 10.1093/fampra/cmx135

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  4 in total

1.  Psychosocial Syndemics and Multimorbidity in Patients with Heart Failure .

Authors:  Kenneth E Freedland; Judith A Skala; Robert M Carney; Brian C Steinmeyer; Michael W Rich
Journal:  J Psychiatr Brain Sci       Date:  2021-04-13

2.  Lung cancer patients' comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study.

Authors:  Jasmin Bossert; Marion Ludwig; Pamela Wronski; Jan Koetsenruijter; Katja Krug; Matthias Villalobos; Josephine Jacob; Jochen Walker; Michael Thomas; Michel Wensing
Journal:  NPJ Prim Care Respir Med       Date:  2021-01-28       Impact factor: 2.871

3.  Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: new follow-up results of the observational RECODE-HF study.

Authors:  Sigrid Boczor; Marion Eisele; Anja Rakebrandt; Agata Menzel; Eva Blozik; Jens-Martin Träder; Stefan Störk; Christoph Herrmann-Lingen; Martin Scherer
Journal:  BMC Fam Pract       Date:  2021-10-13       Impact factor: 2.497

4.  Heart failure epidemiology and treatment in primary care: a retrospective cross-sectional study.

Authors:  Yael Rachamin; Rahel Meier; Thomas Rosemann; Andreas J Flammer; Corinne Chmiel
Journal:  ESC Heart Fail       Date:  2020-11-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.